We analyzed and compared the area inside and outside the GBM tissue, the latter characterized by a very high percentage of Ki67+ cells, evaluating the CD68+ (total) and CD163+ (M2) macrophages positivity. The gene discussed is CD68; the disease is glioblastoma.